Showing results (361-370 of 559) with videos related to

Sort By:
Pageof 56
Arthritis and Rheumatism|March 4, 1998
Hip osteoarthritis prevalence estimates by three radiographic scoring systemsR Hirsch, R J Fernandes, S R Pillemer, et al.
Diabetes Care|August 7, 2015
Environmentally Driven Increases in Type 2 Diabetes and Obesity in Pima Indians and Non-Pimas in Mexico Over a 15-Year Period: The Maycoba ProjectJulian Esparza-Romero, Mauro E Valencia, Rene Urquidez-Romero, et al.
Vascular Medicine (London, England)|August 9, 2008
Measurement characteristics of the ankle-brachial index: results from the Action for Health in Diabetes studyMark A Espeland, Judith G Regensteiner, Sarah A Jaramillo, et al.
Diabetes Care|May 20, 2011
Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetesRena R Wing, Wei Lang, Thomas A Wadden, et al.
The New England Journal of Medicine|March 14, 1991
Racial differences in the relation between blood pressure and insulin resistanceM F Saad, S Lillioja, B L Nyomba, et al.
Diabetologia|October 1, 1998
Plasma lipoproteins and the incidence of abnormal excretion of albumin in diabetic American Indians: the Strong Heart StudyA Fagot-Campagna, R G Nelson, W C Knowler, et al.
Diabetologia|October 1, 1993
Determinants of end-stage renal disease in Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus and proteinuriaR G Nelson, W C Knowler, D R McCance, et al.
Diabetes/Metabolism Research and Reviews|February 23, 2018
Identification and functional analysis of a novel G310D variant in the insulin-like growth factor 1 receptor (IGF1R) gene associated with type 2 diabetes in American IndiansYunhua L Muller, Graham Skelton, Paolo Piaggi, et al.
Diabetologia|November 1, 1981
HLA-A2 and type 2 (insulin independent) diabetes mellitus in Pima Indians: an association of allele frequency with ageR C Williams, W C Knowler, W J Butler, et al.
Controlled Clinical Trials|September 23, 2003
Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetesDonna H Ryan, Mark A Espeland, Gary D Foster, et al.
Pageof 56